Created on Wednesday, 10 Oct 2018. Posted in Industry
New MedTech campaign: Bringing innovation to the NHS is a new campaign aimed at highlighting how the NIHR supports medical technology and device companies (MedTech) to develop their ideas and products for use in the NHS. The campaign has been designed in response to the EU Regulations for medical devices (MDR) and in vitro diagnostic medical devices (IVDR) which were introduced in May 2017 and which are being phased in over five years. The new regulations require companies to generate and publish more clinical data demonstrating the safety and performance of their product. In addition, cost pressures within the NHS have led to an increased requirement for health economic (cost saving) data before a product will be recommended for implementation. The NIHR is ideally placed to support MedTech companies fulfil these requirements.
Created on Thursday, 07 Sep 2017. Posted in Industry
The NIHR MICs (Medtech and In vitro diagnostic Co-operatives) will build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests. Funding will be provided over five years for leading NHS organisations to act as centres of expertise; bringing together patients, clinicians, researchers, commissioners and industry.
The NIHR MICs with launch 1 January 2018
The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS. This could include innovations such as digital technologies to help patients manage their conditions from home instead of a hospital, or to develop new medicines.
Access to this funding will also speed up the time it takes to get new technologies from the lab to patients in the NHS.
The funding is split into 4 packages:
What is intellectual property?
Intellectual Property (IP) is used to define the products of human imagination, creativity and inventiveness. It includes literary and artistic works, inventions, symbols, names, images and designs.
In healthcare IP may come from research or clinical practice. It includes: medical devices; computer software; training materials; service delivery or pathways; project or patient management; tools, scales or instruments; diagnostics; pharmaceuticals; and biotechnology.
How can you protect your idea?
Identifying where Intellectual Property exists is the first step, as unless it is identified, it cannot be captured, protected and exploited. It’s most important keep your ideas confidential from the very beginning. It is very easy to lose IP early on before it has been protected, by publishing research papers, presentations at conferences or meetings and unguarded conversations. Most universities or NHS trusts will have a business or enterprise unit who will help you with protecting and developing your idea. Your research office should be able to advise you who to contact.
What about the confidentiality of your idea when you’re applying for funding?
Who owns the IP?
Legislation in the United Kingdom generally provides that Intellectual Property created by you as an employee in the course of your employment is owned by your employer.
If a project has been funded by the NIHR who owns the Intellectual Property Rights then?
“The Department of Health still expects that where possible and appropriate, the Contractor owns IP arising from research. However, this is not always the case in research with collaborators”. (NIHR FAQs on intellectual property)
Does your employer have an IP policy?
The NHS trust or university you work for should have an IP policy which sets out the principles of the organization with regard to Intellectual Property. This will cover issues about the ownership, protection and use of materials and inventions created by employees.
How can you protect your IP?
Methods of protecting IP will depend on what it is. They include:
Developing your idea
For further information
Today National Voices, a membership organisation of charities working for a stronger patient voice in health and social care, and the Association of the British Pharmaceutical Industry (ABPI), have published a new guide to support charities and companies to forge collaborations in a transparent and effective way.
It sets out four principles on which these partnerships should be based: clarity of purpose; integrity; transparency and independence. It also goes one step further in providing practical advice and support that will help charity and pharma staff think through the practicalities and governance of making such partnerships work.
Revised Industry Costing Templates to reflect the new financial year have been released on the CRN website, Commercial Costing pages. The changes to the template this year are minimal with all revisions detailed in the 'summary of annual revisions' document. All supporting information such as the user guide and step-by-step completion guides have been updated to reflect the revised version. Please use the latest version of the Industry Costing Template to cost any new studies.